ArticleCureus2025
Improving Recognition of Heart Failure With Preserved Ejection Fraction in the Outpatient Setting: A Pilot Study of Readily Useful Clinical Attributes.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart failure with preserved ejection fraction (HFpEF) is increasingly acknowledged as a major clinical condition, yet its diverse presentation often hinders prompt diagnosis and management. This study aims to identify clinical variables obtainable during routine outpatient visits that can help in recognizing subclinical and unrecognized HFpEF or those at risk of developing it.
methodsThis retrospective study analyzed patient data from July 2022 to June 2023 at The University Health Truman Medical Center in Kansas City, Missouri, United States. Chart reviews were performed for patients seen in various outpatient clinics, focusing on those presenting with specific symptoms and comorbidities indicative of HFpEF. Data collected included demographics, vital signs, comorbidities, laboratory values, and echocardiographic findings.
resultsA total of 174 patients (mean age 60 ± 11 years) were included. The majority were female (53%) and White patients. Common comorbidities included hypertension, obesity, diabetes, and chronic kidney disease. Echocardiograms revealed that 93.5% of patients had at least one abnormality, with increased left ventricle (LV) wall thickness in 59.8% and abnormal LV relaxation in 28.7%.
conclusionSymptoms such as dyspnea, exercise intolerance, exertional chest pain, and easy fatigability should prompt early referral to cardiology, particularly in middle-aged and older patients with the relevant comorbidities seen in this study. Incorporating these clinical indicators into electronic medical records can enhance early recognition and diagnosis of HFpEF, improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.